Search

Your search keyword '"Marίlia B. Gomes"' showing total 3 results
Start Over Author "Marίlia B. Gomes"
3 results on '"Marίlia B. Gomes"'

1. Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study

Author

Ali O. Malik, Hungta Chen, Fengming Tang, Paul S. Chan, Andrew Cooper, Marίlia B. Gomes, Vittal Hejjaji, Linong Ji, Kamlesh Khunti, Mikhail Kosiborod, Antonio Nicolucci, Poghni A. Peri-Okonny, Marina V. Shestakova, Jiten Vora, Hirotaka Watada, and Suzanne V. Arnold

Subjects
Type 2 diabetes, Risk factor control, Primary prevention, Surgery, RD1-811, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Background: We sought to describe global patterns in achievement of risk factor control for primary prevention in patients with T2D and explore the association of country's GNI/capita with risk factor control. Methods: The DISCOVER study is a prospective, observational study of patients with T2D from 38 countries enrolled at initiation of second-line glucose-lowering therapy. We examined achievement of risk factor control (glycosylated hemoglobin 0.08 for all). Interpretation: In a global, prospective study of patients with T2D, we found that cardiovascular risk factor control achievement was suboptimal despite 3 years of follow-up in specialized health care systems. Neither country-level nor patient-level socioeconomic factors fully explained this finding.

Published
2022
Full Text
View/download PDF

2. What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the <scp>DISCOVER</scp> study

Author

Andrew Cooper, Linong Ji, Larisa Ramirez, Fabrice Bonnet, Fengming Tang, Marina Vladimirovna Shestakova, Kamlesh Khunti, Paul Leigh, Iichiro Shimomura, Marίlia B. Gomes, Hungta Chen, Hirotaka Watada, Afrah Siddiqui, and Jiten Vora

Subjects
Blood Glucose, medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Glycemic Control, Type 2 diabetes, 030204 cardiovascular system & hematology, Group B, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, Humans, Hypoglycemic Agents, Medicine, In patient, Prospective Studies, Glycated haemoglobin, Therapeutic inertia, Glycated Hemoglobin, business.industry, nutritional and metabolic diseases, Odds ratio, medicine.disease, Confidence interval, Diabetes Mellitus, Type 2, Observational study, business
Abstract

AIMS Glycaemic control is a cornerstone of type 2 diabetes (T2D) management. We assessed factors associated with good long-term glycaemic control in patients with glycated haemoglobin (HbA1c) ≥7.0% at initiation of second-line glucose-lowering therapy, using data from DISCOVER, a global, prospective, 3-year observational study of patients with T2D. MATERIALS AND METHODS This analysis included patients with HbA1c ≥7.0% at baseline (initiation of second-line therapy). Multivariable regression models assessed factors associated with having HbA1c

Published
2021
Full Text
View/download PDF

3. Author response for 'What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated HbA1c (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study'

Author

null Fabrice Bonnet, null Hungta Chen, null Andrew Cooper, null Marίlia B Gomes, null Linong Ji, null Paul Leigh, null Larisa Ramirez Gutierrez, null Marina V Shestakova, null Iichiro Shimomura, null Afrah Siddiqui, null Fengming Tang, null Jiten Vora, null Hirotaka Watada, and null Kamlesh Khunti

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results